The Gaming for Medical Education Research (G4MER) Program (G4MER)

Gaming for Medical Education Research Program: An Investigator-blinded, Randomised Controlled Trial on Serious Games for Doctors, Nurses and Students.

The "G4MER" Program aims to investigate whether serious games add value to medical education in comparison to an online learning package or clinical practice guidelines. The investigators will perform a series of investigator-blinded randomised control trials on doctors, nurses, and medical students at Sydney Children's Hospital. Participants will be given access to their randomly allocated intervention for 8 weeks or 5 days, and will be assessed using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations. Participant attitudes will also be assessed through a mixed-methods questionnaire.

Study Overview

• Status: Unknown
• Conditions: Education, Medical
• Intervention / Treatment: Other: PlayMed; Other: Online Package; Other: Paper Guidelines

Detailed Description

The "G4MER" Program aims to perform a series of randomised control trials on different groups at Sydney Children's Hospital:

1. Study 1A (Formerly titled "Serious Games in Medical Education - a Randomised Control Trial") is already underway and involves Phase 3 medical students at UNSW having 8 weeks access to the game, an Online Package (OP) or NSW State Guidelines on Asthma and Seizure management. Students are then assessed using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations (detailed below).
2. Study 1B is also a randomised control trial similar in design to Study 1A, however it will involve doctors and nurses employed at Sydney Children's Hospital. PlayMed will be compared against the HETI Learning Path Paediatric Clinical Practice Guidelines (Online Package for staff).
3. Studies 2A and 2B are identical to Studies 1A and 1B respectively except participants will have 2 hours access to their educational tool. Participants will then immediately undergo the same assessment using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations The proposed study designs are all blinded randomised control trials. Participants may only be involved in Study 1 or Study 2, not both.

Administration

Studies 1A and 1B Participants allocated to the game and to the OP will be given the appropriate access for 8 weeks (instructions provided in the study envelope). Participants allocated to the guidelines will receive a print-out of the guidelines. Participants will be encouraged to engage with their additional educational tool as often as they wish during their eight weeks. In the 8th last week participants will have their knowledge and clinical performance assessed as outlined below.

Studies 2A and 2B Participants allocated to the game, OP and guidelines will be given 2 hours to utilise their assigned teaching tool. Two hours was selected as an appropriate time-frame in which participants would be able complete all cases of the game or online package, or read through the guidelines. Furthermore, it was chosen as it is more pragmatic and better at assessing short-term retention. Computers will be provided for participants to access the game and OP. The guidelines will be printed for participants to read. Participants will then immediately have their knowledge and clinical performance assess as outlined below.

Assessment

Studies 1A, 1B, 2A and 2B Participants will be assessed for knowledge acquisition and clinical performance. Participant knowledge will be assessed using 10 multiple choice questions (MCQ). Participant clinical skills will be assessed via an observed structured clinical examination (OSCE) administered in the simulation laboratory (immediately after the knowledge test); participants will be tested across two clinical scenarios. Strict marking criteria will be used to ensure standardisation.

• Study Type: Interventional
• Enrollment (Anticipated): 264
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Australia
  • New South Wales
    • Randwick, New South Wales, Australia, 2031
      • Recruiting
      • Sydney Children's Hospital
      • Contact: Michael J Coffey; Phone Number: 011 61 2 9382 5574; Email: michael.coffey@unsw.edu.au
      • Contact: Penelope Uther; Phone Number: 011 61 2 9382 5560; Email: penelope.uther@health.nsw.edu.au

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 99 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Studies 1A and 2A Phase 2 or 3 medical students at UNSW who are enrolled in the Children's Health Course will be eligible
• Studies 1B and 2B Doctors and nurses employed at Sydney Children's Hospital.

Exclusion Criteria:

• Studies 1A and 2A Medical students not actively enrolled at UNSW
• Studies 1B and 2B Doctors and nurses not actively employed at Sydney Children's Hospital.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: PlayMed; PlayMed, a highly immersive role-playing computer game - Focus on Paediatric Asthma and Seizure management	Other: PlayMed; A highly immersive role-playing computer game focused on Paediatric Asthma and Seizure management
Active Comparator: Online Package (OP); Online package (OP) of NSW Health Guidelines - Focus on Paediatric Asthma and Seizure management	Other: Online Package; Online package (OP) of NSW Health Guidelines focused on Paediatric Asthma and Seizure management
Placebo Comparator: Paper Guidelines; Paper NSW Health Guidelines - Focus on Paediatric Asthma and Seizure management	Other: Paper Guidelines; Paper NSW Health Guideline focused on Paediatric Asthma and Seizure management

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Multiple choice quiz score	A paper-based assessment using multiple choice questions designed to test knowledge acquisition for asthma and seizure management. For Studies 1A and 1B, scale 0 to 10, higher is better performance. Studies 2A and 2B, scale from 0 to 15, higher is better.	Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).
Asthma observed structured clinical examination (OSCE) score	An OSCE administered in a high-fidelity simulation lab. A child with an exacerbation of asthma will be presented and the management required will need to be implemented by the participant. For Studies 1A and 1B, subscale from 0 to 15, higher is better, with scores summed with Outcome 3. Studies 2A and 2B, subscale from 0 to 25, higher is better, with scores summed with Outcome 3.	Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).
Seizure observed structured clinical examination (OSCE) scoresimulation lab)	An OSCE administered in a high-fidelity simulation lab. A child with a seizure will be presented and the management required will need to be implemented by the participant. For Studies 1A and 1B, subscale from 0 to 15, higher is better, with scores summed with Outcome 3. Studies 2A and 2B, subscale from 0 to 25, higher is better, with scores summed with Outcome 2.	Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participant attitudes towards educational intervention	Mixed-methods analysis survey. 5-point Likert scale from "Strongly Agree" to "Strongly Disagree".	Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).
Time to specific actions in OSCE scenarios	E.g. calling for help, oxygen supplementation, salbutamol, anti-epileptic drug	Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).
Anti-epileptic medication(s) administered at correct time during OSCE scenario	E.g. Midazolam or diazepam correctly administered at 5 minutes of seizure activity (yes/no).	Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).

Collaborators and Investigators

• Sponsor: The University of New South Wales
• Investigators: Principal Investigator: Michael J Coffey, BMed MD, The University of New South Wales

Study record dates

Study Major Dates

• Study Start (Actual): July 3, 2017
• Primary Completion (Anticipated): February 28, 2022
• Study Completion (Anticipated): April 30, 2022

Study Registration Dates

• First Submitted: August 14, 2018
• First Submitted That Met QC Criteria: September 7, 2018
• First Posted (Actual): September 11, 2018

Study Record Updates

• Last Update Posted (Actual): July 31, 2019
• Last Update Submitted That Met QC Criteria: July 29, 2019
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: HC17160-LNR/17/SCHN/194

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No